Inno Gene SA

  • Market Cap: Micro Cap
  • Industry: Miscellaneous Commercial Services
  • ISIN: PLINNGN00015
PLN
2.32
-0.29 (-11.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Inno Gene SA stock-summary
stock-summary
Inno Gene SA
Miscellaneous Commercial Services
Inno-Gene SA is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
Company Coordinates stock-summary
Company Details
Ul. Sciegiennego 20 , POZNAN None : 60-128
stock-summary
Tel: 48 61 646858548 575 896041
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Krzysztof Krolikowski
Chairman of the Supervisory Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2025)
Net Profit:
0 Million
stock-summary
Industry

Miscellaneous Commercial Services

stock-summary
Market cap

PLN 94 Million (Micro Cap)

stock-summary
P/E

49.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.57

stock-summary
Return on Equity

23.44%

stock-summary
Price to Book

11.38